Sphera Funds Management’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Sphera Funds Management's GPCR Position: Q3 2026 in Review
Sphera Funds Management sold out of Structure Therapeutics (GPCR) in Q3 2026, closing a stake of 28,600 shares — an estimated $1.53M sold.
Sphera Funds Management first reported a position in GPCR in Q1 2025 and held it in 6 quarters. The position peaked at $4.87M in Q3 2025. 169 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Sphera Funds Management reported no remaining Structure Therapeutics position as of Q3 2026 after selling out during the quarter.
- Sphera Funds Management sold 28,600 Structure Therapeutics shares in Q3 2026, an estimated $1.53M.
- Sphera Funds Management first reported a position in Structure Therapeutics in Q1 2025 and held it in 6 quarters.
- Sphera Funds Management's Structure Therapeutics position peaked at $4.87M in Q3 2025.
- 169 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Sphera Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.